Indoco Remedies Limited (NSE:INDOCO)
India · Delayed Price · Currency is INR 218.92
-8.99 (-3.94%)
May 11, 2026, 3:29 PM IST
Indoco Remedies Market Cap
Indoco Remedies has a market cap or net worth of 20.21 billion as of May 11, 2026. Its market cap has decreased by -9.92% in one year.
Market Cap
20.21B
Enterprise Value
30.70B
Revenue
18.49B
Ranking
n/a
PE Ratio
n/a
Stock Price
218.92
Market Cap Chart
Since January 14, 2005, Indoco Remedies's market cap has increased from 4.66B to 20.21B, an increase of 333.63%. That is a compound annual growth rate of 7.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 20.21B | -6.63% |
| Dec 31, 2025 | 21.64B | -29.33% |
| Dec 31, 2024 | 30.62B | -15.91% |
| Dec 29, 2023 | 36.42B | -2.82% |
| Dec 30, 2022 | 37.47B | -10.49% |
| Dec 31, 2021 | 41.86B | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 56.17B |
| Innova Captab | 50.11B |
| RPG Life Sciences | 40.74B |
| Orchid Pharma | 35.68B |
| Solara Active Pharma Sciences | 25.31B |
| Windlas Biotech | 17.37B |
| Jagsonpal Pharmaceuticals | 14.59B |
| Beta Drugs | 13.35B |